Author

Robert R. Carroll

Observed names: R Carroll, R. Carroll, R.R. Carroll, ROBERT R. CARROLL, Robert Carroll, Robert R Carroll

Observed institutions: Amgen (United States), Mayo Clinic, Medical University of Białystok, University of Pittsburgh, University of Florida Health, University of Florida, Utah Cancer Specialists, Magee-Womens Hospital, Highlands Oncology Group, North Florida/South Georgia Veterans Health System, UPMC Hillman Cancer Center, Mayo Clinic in Florida

OpenAlex ID: A5035530459

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

2020 · Sandra M Swain, David Miles, et al. · The Lancet Oncology · 917

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

2017 · Miguel Martin, Frankie A Holmes, et al. · The Lancet Oncology · 587

First and Subsequent Cycle Use of Pegfilgrastim Prevents Febrile Neutropenia in Patients With Breast Cancer: A Multicenter, Double-Blind, Placebo-Controlled Phase III Study

2005 · Charles L. Vogel, Marek Z. Wojtukiewicz, et al. · Journal of Clinical Oncology · 483

Zoledronic Acid Inhibits Adjuvant Letrozole–Induced Bone Loss in Postmenopausal Women With Early Breast Cancer

2006 · Adam Brufsky, W. Graydon Harker, et al. · Journal of Clinical Oncology · 322

Squamous cell carcinoma of the anal canal

2001 · Sandra E Mitchell, William M Mendenhall, et al. · International Journal of Radiation Oncology*Biology*Physics · 74

The Effect of Zoledronic Acid on Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: The Z-FAST Study 5-Year Final Follow-Up.

2009 · A. Brufsky, G. Harker, et al. · Cancer Research · 59

Zoledronic acid (ZA) effectively inhibits cancer treatment-induced bone loss (CTIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (Let): 12 mos BMD results of the Z-FAST trial

2005 · A. Brufsky, W. G. Harker, et al. · Journal of Clinical Oncology · 54

Dose-Intense Ifosfamide/Doxorubicin/Cisplatin Based Chemotherapy for Osteosarcoma in Adults

2002 · Shailesh J. Patel, James W. Lynch, et al. · American Journal of Clinical Oncology · 45

Intravenous immunoglobulin administration in the treatment of severe chronic immune thrombocytopenic purpura

1984 · Robert R Carroll, Ward D Noyes, et al. · The American Journal of Medicine · 33

High-Dose Intravenous Immunoglobulin Therapy in Patients With Immune Thrombocytopenic Purpura

1983 · Robert R. Carroll · JAMA · 30

Canebrake Rattlesnake Envenomation

1997 · Robert R Carroll, Edward L Hall, et al. · Annals of Emergency Medicine · 24

Induction chemotherapy and radiation therapy for T4 oropharyngeal carcinoma

1999 · Rakesh M. Nathu, William M. Mendenhall, et al. · Radiation Oncology Investigations · 16

Current management of squamous cell carcinoma of the anal canal

1994 · W.M. Mendenhall, M.D. Sombeck, et al. · Surgical Oncology · 14

Spontaneous disappearance of an IgA anti‐factor IX inhibitor in a child with christmas disease

1984 · Robert R. Carroll, Richard S. Panush, et al. · American Journal of Hematology · 7

Bone-specific alkaline phosphatase (BSAP) and serum N-telopeptide (sNTX) as predictors of bone loss in postmenopausal women with early breast cancer receiving letrozole as adjuvant therapy: a 5-year study (Z-FAST).

2009 · A Brufsky, G Harker, et al. · Cancer Research · 3

Evaluation of Intravenous Immune Serum Globulin in Immune Thrombocytopenia: Preliminary Results

1985 · Robert R. Carroll · Vox Sanguinis · 1

Hematuria Unrelated to Hemophilia in a Hemophiliac

1982 · ROBERT R. CARROLL, CRAIG S. KITCHENS · Southern Medical Journal

Works count: 17

Citation count: 2,669

H-index: 13

I10-index: 13